$OPTH News
Last published 2w ago
- 2w agoOPTHOptimi Health Establishes Optimi Australia Pty Ltd as Dedicated Distribution and Business Development EntityGlobeNewswireVANCOUVER, British Columbia, Oct. 26, 2026 (GLOBE NEWSWIRE) -- Optimi Health Corp. (NASDAQ:OPTH, CSE:OPTI, FSE: 8BN)) (the "Company" or "Optimi"), a commercial-stage pharmaceutical developer and
- 3w agoOPTHOptimi Health Completes MDMA Production for Phase 3 PTSD Trial in Canada, MAPS Trial in Israel and Commercial Supply in AustraliaGlobeNewswireBatch sufficient to supply the proposed Canadian Phase 3 trial, a clinical trial in Israel in partnership with MAPS and a commercial export to treat PTSD in Australia Health Canada-authorized trial to evaluate efficacy
- 1mo agoOPTHOptimi Health to Present at the ThinkEquity ConferenceGlobeNewswireVANCOUVER, British Columbia, Oct. 07, 2026 (GLOBE NEWSWIRE) -- Optimi Health Corp. (NASDAQ:OPTH) (CSE:OPTI) (FSE: 8BN) ("Optimi" or "the Company"), a commercial-stage pharmaceutical manufacturer and
- 1mo agoOPTHOptimi Health Expands Clinical Program with Phase 3 Trial Evaluating MDMA-Assisted Therapy for Post-Traumatic Stress DisorderGlobeNewswireVANCOUVER, British Columbia, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Optimi Health Corp. (NASDAQ:OPTH) (CSE:OPTI) (FSE: 8BN) ("Optimi" or the "Company"), a commercial-stage pharmaceutical manufacturer of
- 2mo agoOPTHOptimi Health to Initiate Phase 2 Clinical Trial Evaluating Psilocybin-Assisted Therapy for Major Depressive DisorderGlobeNewswireHealth Canada-authorized trial to evaluate a single supervised dose of natural psilocybin, with dosing expected to be completed by the end of 2027 Up to 200 participants at sites across Canada, among the largest
- 2mo agoOPTHOptimi Health to Participate in the H.C. Wainwright 28th Annual Global Investment ConferenceGlobeNewswireVANCOUVER, British Columbia, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Optimi Health Corp. (NASDAQ:OPTH) (CSE:OPTI) ("Optimi" or the "Company"), a commercial-stage pharmaceutical manufacturer of regulated
- 2mo agoOPTHOptimi Health Establishes Discretionary Equity FacilityGlobeNewswireVANCOUVER, British Columbia, Aug. 14, 2026 (GLOBE NEWSWIRE) -- Optimi Health Corp. (NASDAQ:OPTH) (CSE:OPTI) (FSE: 8BN) (the "Company" or "Optimi"), a commercial-stage pharmaceutical manufacturer of
- 4mo agoOPTHOptimi Health Completes Psilocybin Export to Australia for Patients With Treatment-Resistant DepressionGlobeNewswireOptimi’s 5mg psilocybin capsules are prescribed in Australia for treatment-resistant depression.The export marks Optimi’s third commercial shipment since launching the 5mg psilocybin capsules in September 2025.
- 4mo agoOPTHOptimi Health Launches Standardized Microdose Psilocybin Products for Clinical ResearchPR NewswireTwo naturally derived finished drug products, at 1mg and 2mg, give research organizations the consistent, validated doses required for controlled...
- 4mo agoOPTHOptimi Health Launches Standardized Microdose Psilocybin Products for Clinical ResearchGlobeNewswireTwo naturally derived finished drug products, at 1mg and 2mg, give research organizations the consistent, validated doses required for controlled studies New microdose formats extend Optimi's psilocybin range, which
- 5mo agoOPTHOptimi Health Completes First Export of Psilocybin to the United Kingdom for Phase 2 Clinical TrialPR NewswireThe shipment of naturally derived psilocybin, comprising both biomass and 5mg capsules, supports a planned Phase 2 clinical trial in the United...
- 5mo agoOPTHOptimi Health Completes First Export of Psilocybin to the United Kingdom for Phase 2 Clinical TrialGlobeNewswireVANCOUVER, British Columbia, June 10, 2026 (GLOBE NEWSWIRE) -- via IBN – Optimi Health Corp. (NASDAQ:OPTH) (CSE:OPTI) (FSE: 8BN0) (the "Company" or "Optimi"), a commercial-stage pharmaceutical
- 5mo agoOPTHOptimi Health Secures Ibogaine Supply and Commences Finished Drug Product DevelopmentPR NewswireRecent US executive order named ibogaine compounds among the psychedelic therapies prioritized for accelerated FDA review and expanded patient access ...
- 5mo agoOPTHOptimi Health Secures Ibogaine Supply and Commences Finished Drug Product DevelopmentGlobeNewswireRecent US executive order named ibogaine compounds among the psychedelic therapies prioritized for accelerated FDA review and expanded patient access Ibogaine is under investigation to treat PTSD, opioid use disorder
- 5mo agoOPTHOptimi Health Completes Commercial Psilocybin Production to Address Treatment-Resistant Depression in AustraliaGlobeNewswireOptimi's 5mg psilocybin capsules are prescribed commercially for treatment-resistant depression in Australia, with additional product from the run earmarked for planned clinical trials in the United States and Europe
- 5mo agoOPTHOptimi Health Welcomes Expanded Psychedelic-Assisted Therapy Access Under Updated Authorized Prescriber Framework in AustraliaPR NewswireUpdated TGA recommendations broaden therapist eligibility, accept a wider range of treatment settings, and reinforce Australia's position as the...
- 5mo agoOPTHOptimi Health Welcomes Expanded Psychedelic-Assisted Therapy Access Under Updated Authorized Prescriber Framework in AustraliaGlobeNewswireUpdated TGA recommendations broaden therapist eligibility, accept a wider range of treatment settings, and reinforce Australia's position as the world's leading commercial market for prescribed psilocybin and
- 5mo agoOPTHDiamond Equity Research Initiates Coverage on Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN)GlobeNewswireNew York, May 27, 2026 (GLOBE NEWSWIRE) -- Diamond Equity Research LLC, an equity research firm with a focus on small capitalization public companies has initiated coverage of Optimi Health Corp. (NASDAQ:OPTH)
- 5mo agoOPTHSRXHSRx Health Solutions and EMJX Invest in Recent IPO and Commercial-Stage Pharmaceutical Company of Psychedelics, Optimi Health Corp. (OPTH)GlobeNewswireNORTH PALM BEACH, Fla., May 21, 2026 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company") and EMJ Crypto Technologies ("EMJX"), a digital-asset treasury operating platform with
- 5mo agoOPTHOptimi Health Announces Pricing of Oversubscribed US$15 Million Public Offering and Nasdaq UplistingPR NewswireCommon Shares to Trade on the Nasdaq Capital Market Under the Symbol "OPTH" VANCOUVER, BC, May 20, 2026 /PRNewswire/ - Optimi Health Corp. (NASDAQ:...